Report #2830192

Received Mar 7, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Hypersensitivity

Symptom narrative

Nees allergy; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of allergy in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced allergy (Verbatim: Nees allergy). The outcome of the allergy was not reported. It was unknown if the reporter considered the allergy to be related to Arexvy. It was unknown if the company considered the allergy to be related to Arexvy. Additional Information: GSK Receipt Date: 27-FEB-2025 The reporter reported that patient received Arexvy vaccine and experienced allergy and needs alleygy information.